⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9364312 | 1.00 | — | — | |
| SCHEMBL888366 | 0.80 | — | — | |
| SCHEMBL29154803 | 0.80 | — | — | |
| SCHEMBL7621371 | 0.78 | — | — | |
| SCHEMBL727473 | 0.76 | — | — | |
| SCHEMBL22746947 | 0.76 | — | — | |
| SCHEMBL2783019 | 0.76 | — | — | |
| SCHEMBL2736332 | 0.76 | — | — | |
| SCHEMBL2611056 | 0.76 | — | — | |
| SCHEMBL7618573 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015158-A1 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2011-01-20 | — | — | US | claimed |
| EP-2234608-A2 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | Viamet Pharmaceuticals, Inc. (US) | 2010-10-06 | — | — | EP | claimed |
| WO-2009105140-A2 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2009-08-27 | — | — | WO | claimed |
| CN-100351249-C | Quinolinone derivatives as tyrosine kinase inhibitors | CHIRON CORP (US) | 2007-11-28 | — | — | CN | claimed |
| JP-5045787-A | — | — | None | — | — | JP | disclosed |
| JP-5045790-A | — | — | None | — | — | JP | disclosed |
| JP-5045795-A | — | — | None | — | — | JP | disclosed |
| WO-2024145346-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | LYGG CORPORATION (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240132628-A1 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NEUBASE THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20230174985-A1 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NEUBASE THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-11603530-B2 | Modified peptide nucleic acid compositions | NEUBASE THERAPEUTICS, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| WO-2022261030-A1 | OLIGONUCLEOTIDE ANALOGUE MODULATORS OF ONCOGENES | NEUBASE THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| EP-0224919-B1 | NEW THIAZOLE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-14 | — | — | EP | disclosed |
| US-4963655-A | ANTITUMOR AGENTS; VIRICIDES, AIDS, HERPES; ANTICANCER AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1990-10-16 | — | — | US | disclosed |
| EP-0325973-A2 | Recording liquid for ink-jet printing | BASF Aktiengesellschaft (DE) | 1989-08-02 | — | — | EP | disclosed |
| US-4742057-A | Antiallergic thiazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| EP-0224919-A2 | New thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-06-10 | — | — | EP | disclosed |
| EP-0090063-B1 | PROCESS FOR MAKING N-(2-AMINOETHYL)AMIDES FROM OXAZOLINES AND AMINES | THE DOW CHEMICAL COMPANY (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4207246-A | REACTING UNSATURATED DIESTER WITH ORGANOSILOXANE CONTAINING SILICONBONDED HYDROGEN, CATALYST | Consortium f/ur Elektrochemische Industrie GmbH (DE) | 1980-06-10 | — | — | US | disclosed |
| US-4206117-A | Pyridinyl aminoalkyl ethers | BASF AKTIENGESELLSCHAFT (DE) | 1980-06-03 | — | — | US | disclosed |